Akums enters into Rs 1750 crore contract to supply pharma products to Europe
global pharmaceutical company to manufacture and supply pharmaceutical formulations in the European market.
ET Year-end Special Reads
Corporate Kalesh: Top family disputes of India Inc in 2024
The world of business lost these eminent people in 2024
Fast, faster, fastest: How 2024 put more speed into your shopping
Akums didn't disclose the name of the company it will be supplying.
As part of the agreement, the New Delhi-based contract development and manufacturing organisation (CDMO) will receive an upfront payment of €100 million (Rs 880 crores) for product development and site approval from European authorities.
Under this collaboration, Akums will produce and supply multiple SKUs of oral liquid formulations, which the partner company will market across various European countries.
The commercial supply of these products is expected to begin in 2027 and will continue to be supplied till 2032.
Entrepreneurship
Crafting a Powerful Startup Value Proposition
By — Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience
Web Development
Mastering Full Stack Development: From Frontend to Backend Excellence
By — Metla Sudha Sekhar, IT Specialist and Developer
Marketing
Digital Marketing Masterclass by Pam Moore
By — Pam Moore, Digital Transformation and Social Media Expert
Web Development
12-Factor App Methodology: Principles and Guidelines
By — Prince Patni, Software Developer (BI, Data Science)
Finance
A2Z Of Finance: Finance Beginner Course
By — elearnmarkets, Financial Education by StockEdge
Strategy
ESG and
